Recent advances in the management of lipid disorders. Toronto, Ontario, October 4.
D003327:Coronary Disease / Q000209:etiology; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006946:Hyperinsulinism / Q000473:pathology; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011973:Receptors, LDL
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011973:Receptors, LDL